Skip to main content
# Title Department Research Member Research Year
21 Field and Nodal Irradiation in Early stage Hodgkin’s lymphoma: A single institution study Department of Radiotherapy and Nuclear medicine Dr. Asmaa elsayed abdelsalam /hasaballah 2024
22 Beta Endorphins, Interleukin 1 and Interleukin 38 in Covid Patients Associated with Neuropsychological Manifestations Department of Clinical Pathology Dr. Engy adel shafeek 2024
23 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2024
24 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Salah Mabrouk Khallaf Abd Rabou 2023
25 Value of FoxO3a Gene Expression in Pediatric Acute Lymphoblastic Leukemia Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2023
26 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2023
27 Could Local Surgery Improve Survival in Stage IV Breast Cancer? Department of Surgical Oncology Prof. Hesham Mahmoud Mohamed Mahmoud 2023
28 Surgical Outcomes of Laparoscopic-assisted Distal Gastrectomy Versus Totally Laparoscopic Distal Gastrectomy Billroth I for Gastric Cancer Department of Surgical Oncology Dr. Badawy, Mohammed Ahmed Mohammed 2023
29 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2023
30 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Shimaa Hassan Shabaan Hassan 2023